The meeting will feature panel discussions led by patients and patient advocates.
The meeting, a part of the FDA’s Patient-Focused Drug Development initiative, will be held at the FDA’s White Oak Campus in Silver Spring, Md.
More articles on gastroenterology:
6 reasons patients avoid undergoing screening colonoscopy
Dr. Atif Iqbal: Using the LINX device for GERD treatment
7 statistics on Match Day for GI
